TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 13 | 12 | 3 | 14 | -9 | -39 | -1 |
| P | %wins | 100 | 100 | 50 | 50 | 50 | 0 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/18/17 06:09 | 12/14/17 | ACUR | Acura Pharmaceuticals, Inc | NY | Health | Drug | Pharmaceutical Preparations | Emigh James F | IL | O | VP Corpo | P | 40 | 0.1000 | 0 | 400 | 999% | 440 | D | ||||||||||||||
5/19/14 09:28 | 5/16/14 | ACUR | Acura Pharmaceuticals, Inc | NY | Health | Drug | Pharmaceutical Preparations | Emigh James F | IL | O | VP Corpo | P | 18 | 1.21 | 0 | 15 | 8 | 198 | D | -53 | -44 | -27 | -34 | -14 | -8 | -5 | 0 | 0 | 1 | -11 | -27 | -54 | -34 |
8/15/11 15:12 | 8/12/11 | ACUR | Acura Pharmaceuticals, Inc | NY | Health | Drug | Pharmaceutical Preparations | Emigh James F | IL | O | VP Marke | P | 13 | 2.60 | 0 | 5 | 3 | 171 | D | -55 | 6 | -21 | -40 | -34 | -19 | -23 | -13 | 26 | 23 | 16 | 54 | 36 | -43 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |